Apparatus

HBM1020 is the world's first anti-B7H7 monoclonal antibody to be formally approved for clinical phase.

A new approach to cancer treatment!

New therapy for lung cancer!

It is reported that researchers from Georgia Institute of Technology and Piemonte Heart Institute are using customized 3D printed heart valve models based on patients' heart CT scanning to improve the success rate of transcatheter aortic valve replacement (TAVR) surgery. Their aim is to avoid perivalvular leakage. This research has been published in JACC: Cardiovascular Imaging.

A dendritic cell vaccine has shown excellent results in the treatment of glioblastoma, significantly extending the survival of patients with a good safety profile, according to new data from a global clinical trial. To date, patients who have benefited for the longest time have survived for more than eight years.

The Fraunhofer Institute in Germany has now developed two techniques that could make testing faster and cheaper.

The results of a new study recently showed that Olutasidenib monotherapy in patients with relapsed/refractory acute myeloid leukaemia carrying the IDH1 mutation elicited high rates of complete remission with manageable toxicity.

The dental profession can use these tools as a guide to improve the sustainability of their working environment and to recognise their efforts by tracking progress.

SKB264 is currently in Phase II and Phase III clinical trials as a single agent/combination for multiple tumour types.

The impact of AlphaFold on protein structure prediction has been transformative.